#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Transitional cell carcinoma Atypical haemolytic uraemic syndrome Pemphigus General anaesthesia Retinal dystrophy Chronic myelomonocytic leukaemia Epileptic encephalopathy Paget's disease of the vulva Phenylketonuria Cystic fibrosis Malignant fibrous histiocytoma Idiopathic intracranial hypertension Nasopharyngeal cancer Fibrous dysplasia of bone Neurotrophic keratopathy More trials…
Learn about Rare Diseases

Progressive supranuclear palsy – Diagnostics Skin angiosarcoma Noonan syndrome – Diagnostics Basal cell naevus syndrome – Treatment Biotinidase deficiency – Diagnostics Mantle cell lymphoma Inclusion body myositis – Trials in Disease Marfan’s syndrome Shprintzen-Goldberg syndrome – Life with Disease Gaucher’s disease type III – Life with Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Talazoparib Stro-002 Urea Aluminium Oxide Nelivaptan Elritercept GS-248 Ambroxol Hydrochloride CYCLIZINE HYDROCHLORIDE Hu5F9‐G4 Nandrolone Decanoate Abelacimab Propofol Felzartamab REGN7544 Indocyanine Green Livmoniplimab Tetracosactide Aceclofenac L-SERINE More therapies…

Learn about Your Condition

Peripheral ischaemia Hydrocephalus Piriformis syndrome Bronchopulmonary dysplasia Myositis Tendon rupture Corneal graft rejection Lymphocytic lymphoma Eye pain Angelman's syndrome Lichenoid keratosis Neurodegenerative disorder Psychological trauma Skin papilloma Coronary artery occlusion More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Malignant melanoma of eyelid

Study on the Safety and Effects of ATL001 and Nivolumab for Adults with Metastatic or Recurrent Melanoma

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Atl001
- Nivolumab
Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with Advanced Melanoma with BRAF V600E/K Mutation

Not recruiting

3 1 1
Investigated Drugs:
+5
Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with BRAF V600E/K Mutation-Positive Melanoma After Anti-PD-1 Therapy

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Malignant melanoma of eyelid

Study on the Safety and Effects of ATL001 and Nivolumab for Adults with Metastatic or Recurrent Melanoma

Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with Advanced Melanoma with BRAF V600E/K Mutation

Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with BRAF V600E/K Mutation-Positive Melanoma After Anti-PD-1 Therapy

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies